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Replacement of N-Acetylquinovosamine with its Hexosyl-4-Ulose
Precursor*
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Abstract: The O-antigen polysaccharide (OPS) of Rhizobium etli CE3 lipopolysaccharide (LPS)
is linked to the core oligosaccharide via an N-acetylquinovosaminosyl (QuiNAc) residue. A
mutant of CE3, CE166, produces LPS with reduced amounts of OPS, and a suppressed mutant,
CE166α, produces LPS with nearly normal OPS levels. Both mutants are deficient in QuiNAc
production. Characterization of OPS from CE166 and CE166α showed that QuiNAc was
replaced by its 4-keto derivative, 2-acetamido-2,6-dideoxyhexosyl-4-ulose. The identity of this
residue was determined by NMR and mass spectrometry, and by gas chromatography-mass
spectrometry analysis of its 2-acetamido-4-deutero-2,6dideoxyhexosyl derivatives produced by
reduction of the 4-keto group using borodeuteride. Mass spectrometric and methylation analyses
showed that the 2-acetamido-2,6-dideoxyhexosyl-4-ulosyl residue was 3-linked and attached to
the core-region external Kdo III residue of the LPS, the same position as that of QuiNAc in the
CE3 LPS. DNA sequencing revealed that the transposon insertion in strain CE166 was located in
an open reading frame whose predicted translation product, LpsQ, falls within a large family of
predicted open reading frames, which includes biochemically characterized members that are
sugar epimerases and/or reductases. A hypothesis to be tested in future work is that lpsQ
encodes UDP-2-acetamido-2,6-dideoxyhexosyl-4-ulose reductase, the second step in the
synthesis of UDP-QuiNAc from UDP-GlcNAc.

The bacterial species Rhizobium etli forms a nitrogen-fixing symbiosis with bean
(Phaseolus vulgaris). During the symbiotic interaction of R. etli with bean, the bacteria eventually
penetrate the root nodule cells via a plant-derived infection thread and are, thus, surrounded by
the plant plasma membrane upon entering the nodule cell. The R. etli lipopolysaccharide (LPS)1
plays an essential role in the infection of the host cells. Mutants that lack the O-chain
polysaccharide (OPS) of the LPS or have reduced amounts of OPS fail to infect the host cells,
resulting in root nodules that are devoid of bacteria and are unable to fix nitrogen (1–3). Similar
results have also been observed for LPS mutants of R. leguminosarum biovar viciae, and
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Bradyrhizobium japonicum (for a review, see Ref. 4).
The complete glycosyl sequence of the R. etli parent strain OPS (5) and core region (6, 7)
is shown in Fig. 1. The parent OPS consists of exactly five trisaccharide repeating units,
composed of one residue each of fucose (Fuc), 3-O-methyl-6-deoxytalose (3Me6dTal), and
methylglucuronate (GlcAMe). Considerable structural heterogeneity exists due to variability in
the degree of endogenous O-methylation at fucosyl residues and due to partial loss of O-acetyl
and methyl ester groups during mild acid hydrolysis or while in solution. As depicted in Fig. 1, the
OPS repeating units are “capped” at the nonreducing end by a single residue of tri- or
di-O-methylfucose (2,3,4-TOMeFuc or 2,3-DOMeFuc). The repeating unit located toward the
proximal end of the OPS is attached to a nonrepeating glycosyl sequence, defined as the outer
core region, consisting of fucose, mannose, and N-acetylquinovosamine (QuiNAc) (residues
B–D); the QuiNAc residue of this outer core trisaccharide links the OPS repeating units to O-4 of
the 3-deoxy-2-octulosonic acid (Kdo) III residue, itself uniquely located at the distal end of the
inner core region.
A mutant of R. etli CE3 that produces an LPS with reduced amounts of OPS is CE166.
This mutant also fails to invade the root nodule cells (8), and analysis of its LPS showed that it
lacked QuiNAc (8). The amount of OPS could be restored to nearly normal levels by suppression
with multiple copies of a plasmid containing the lpsα region, which contains numerous genes
encoding for the synthesis of the OPS but does not contain the gene mutated in CE166. The
suppressed mutant, called CE166α, is able to form nitrogen-fixing nodules, but they form more
slowly and are more widely dispersed on the host root compared with nodules formed by the
parent, CE3 (8). The LPS from CE166α, while nearly normal in amount, also does not contain
appreciable levels of QuiNAc (8). Thus, these results suggested that QuiNAc, or LPS structural
features that require QuiNAc, are essential for normal nodulation of bean. An earlier report by
Hrabak et al. (9) suggested that QuiNAc plays a role in the lectin-mediated interaction of R. trifolii
with clover. A high level of OPS-containing LPS is essential for symbiotic infection; therefore, the
synthesis of QuiNAc could play a role in regulating the level of OPS on the bacterial surface and,
thereby, the symbiotic virulence of R. etli CE3.
Since QuiNAc is a key glycosyl residue linking the OPS to the core region of the LPS (see
Fig. 1), it was not understood how mutant CE166 or CE166α could produce LPS that contained
the OPS but lacked QuiNAc. Here we show that in the LPSs from these mutants, QuiNAc is
replaced by 2-acetamido-2,6-dideoxyhexosyl-4-ulose, a likely biosynthetic precursor of QuiNAc
synthesis.
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Experimental Procedures
Growth of Bacteria
R. etli strain CE3, the Tn5-derived mutant CE166, and the suppressed mutant CE166α
were grown in tryptone/yeast extract supplemented with Ca2+ (10, 11). Bacteria were harvested
by centrifugation at late log/early stationary phase.
Isolation of Lipopolysaccharide and the O-specific Polysaccharide
Lipopolysaccharides were extracted using the hot phenol-water procedure, and purified
by ribonuclease treatments and size exclusion chromatography (SEC) on Sepharose CL-4B as
described previously (1, 12). The OPSs were isolated from the total LPS by mild hydrolysis in
1.0% acetic acid at 105 °C for 2 h. The hydrolysates we re subjected to freeze/thawing (three
repetitions), and the precipitated lipid A was removed by ultracentrifugation at 160,000 X g for 1 h.
The supernatants, containing the solubilized O-polysaccharide and the core region
oligosaccharides, were passed through a column of polymyxin-agarose to remove remaining
traces of free lipid A and intact LPS (6). The flow-through eluants were then chromatographed on
Bio-Gel P-10 (45–90-µm fine, 1.5 X 90 cm) in 50 mM ammonium formate, pH 6.5, to separate the
O-polysaccharides from the core oligosaccharides.
Analysis of Glycosyl Residues
Carbohydrate compositions of OPS and derived fractions were determined by gas
chromatography-mass spectrometry (GC-MS) (electron impact) analysis of the trimethylsilyl
methyl glycosides (13) using a 30-meter DB-5 fused silica capillary column (J&W Scientific).
Carbohydrate identities of neutral and amino sugars and the location of endogenous O-methyl
groups were determined by GC-MS analysis of the alditol acetates, using a 30-meter SP-2330
capillary column (Supelco) (13). Carboxylated glycosyl residues, and those containing keto
functions, were also analyzed as the alditol acetates, requiring separate reduction steps in a
specific sequence: 1) prereduction of OPS at the C-2 ketosidic position of terminal Kdo residues,
using NaBD4 in dilute NH4OH, yielding the diastereomeric alditols; 2) normal acid hydrolysis (2 M
trifluoroacetic acid, 105 °C, 3 h) to cleave all glycosi dic linkages and cause formation of the Kdo
1,4-lactone (14), reduction at C-1 of the Kdo lactone using NaBD4 in water (14), followed by
reduction of all remaining glycosyl anomeric centers with excess NaBD4; 4) methyl esterification
of uronic acids (and other remaining carboxylated sugars) using 0.2 M methanolic HCl at 80 °C
for 30 min; 5) reduction of methyl-esterified sugars with NaBD4 in water; 6) peracetylation. Using
this multistep procedure, reduction at C-4 of 4-hexulose residues was most efficient, presumably
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due to the use of three separate reduction steps. Results described below indicate that
prereduction (step 1), prior to acid hydrolysis and alditol acetate preparation, may be the major
factor leading to efficient C-4 reduction of the acid-labile 4-hexulose residues. During the
preparation of alditol acetates by the normal procedure, with only one reduction step following
acid hydrolysis, the yield of C-4 deuterated derivatives was barely detectable. For glycosidic
linkage analysis, OPS samples were prereduced with NaBD4 prior to methylation in order to
stabilize the reducing end residue. Subsequently, Kdo and uronic acid linkages were identified
by sequential permethylation (Hakomori method), reduction of carboxymethyl groups with lithium
triethylborodeuteride (Aldrich), remethylation (Hakomori), mild hydrolysis (0.1 M trifluoroacetic
acid, 100 °C, 30 min) to cleave any internal ketosidi c linkages, reduction (NaBD4), normal
hydrolysis (2 m trifluoroacetic acid, 121 °C, 2 h), conv ersion to the partially methylated alditol
acetates (13), and GC-MS analysis. OPS samples that were not prereduced prior to methylation
failed to yield any Kdo derivatives (due to alkaline degradation of the reducing end Kdo residues)
and also showed low yields of C-4 deuterium incorporation into the 4-hexulosyl residue.
Chemical Modifications
De-O-acetylation of O-polysaccharides was performed in 10% aqueous NH4OH at 23 °C
for 5 h. The progress of the reaction was followed by 1H NMR and matrix-assisted laser
desorption ionization-time-of-flight mass spectrometry. Total β-elimination (depolymerization)
was performed on portions of the native or de-O-acetylated OPS as follows. The polysaccharide
(8–30 mg) was reduced with NaBD4 (10 mg/3 ml of 0.3 M NH4OH) overnight to stabilize the
reducing end glycosyl residue and then methyl-esterified by treating three times with methanol
containing 1–2 drops of aqueous 1 M HCl and evaporating to dryness. The fully esterified
polysaccharide was then treated with aqueous NaOH (0.25 M,38 °C, 18 h), and the products
were chromatographed by size exclusion chromatography (SEC) using Bio-Gel P-10 (Bio-Rad)
(1.5 X 92 cm) in water, or on a Superdex-Peptide HR 10/30 column (Amersham Biosciences) in
50 mM NH4HCO3. Column eluants were monitored by refractive index and for the presence of
∆4,5 hexuronosyl residues by measuring the absorbance at 232 nm. Fractions containing
oligosaccharides were combined and analyzed by electrospray ionization-mass spectrometry
(ESI-MS) and GC-MS.
Identification of OPS Reducing End Residue by Reduction with Borodeuteride
The glycosyl residue located at the reducing end of the various OPS fractions was
identified by reduction, using borodeuteride in NH4OH as described above, followed by normal
hydrolysis and peracetylation as described. Derivatives were analyzed using the SP-2330
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column. This procedure yields the α/β peracetates of all internal residues and the deuterated
alditol acetate of the reducing end residue.
Mass Spectrometry
ESI-MS was performed on a SCIEX API-III triple quadrapole mass analyzer (PE/SCIEX,
Thornhill, Ontario, Canada) operated in the positive ion mode with an orifice potential of 35–50 V
(5). Spectra are the accumulation of 10–60 scans collected over the m/z range 200–2400 with a
mass step of 0.2–1.0 atomic mass units at 1 ms/step. OPS were desodiated by dialysis, followed
by treatment with a strong cation exchange resin (H+ form), and then filtered using 0.45-µm nylon
spin filters and stored in polypropylene tubes. Underivatized samples were analyzed at a
concentration of 2 µg/µl with a flow rate of 3–5 µl/min using a solution of 15% (v/v) methanol in
deionized water containing 0.5% (v/v) acetic acid. The predicted molecular weights of the various
OPSs and derived oligosaccharides were calculated using the following average incremental
mass values, based on the atomic weights of the elements: hexose, 162.1424; hexuronic acid,
176.1259; 4-deoxyhex-4-enopyranosiduronic acid, 158.1106; Kdo, 220.1791; anhy-dro-Kdo,
202.1638; 6-deoxyhexose, 146.1430; mono-O-methyl-6-deoxyhexose, 160.1699;
di-O-methyl-6-deoxyhexose, 174.1968; tri-O-methyl-6-deoxyhexose, 188.2236;
2-acetamido-2,6-dideoxyhexose, 187.1955; 2-acetamido-2,6-dideoxyhexosyl-4-ulose, 185.1796;
O-acetyl, 42.0373; free reducing end, 18.0153.
NMR Spectroscopy
Proton NMR spectra of the native and de-O-acylated OPS samples were recorded at
35 °C in D 2O at 2 mg/ml. Spectra were recorded on a Varian 500-MHz spectrometer using the
Varian software.
DNA Cloning and Sequence Determination
The 10.3-kb EcoRI fragment of CE166 DNA carrying the Tn5 insertion was cloned in
vector pBlueScriptKS- (pBKS) (Stratagene). This plasmid (pET166) was digested with BamHI to
allow separate subcloning of the inverted repeats at the termini of Tn5 and the rhizobial DNA
connected to each Tn5 terminus. p166LK is a religated (circularized) BamHI fragment from
pET166 carrying most of the pBKS and 2.0 kb of rhizobial DNA connected to the Km
resistance-conferring half of Tn5. Plasmid p166RS is pBKS in which the BamHI site carries 1.2
kb of rhizobial DNA connected to the other half of the Tn5 from pET166. Sequencing of these
subcloned rhizobial DNA fragments was carried out by the Sanger method at the University of
Wisconsin (Milwaukee, WI) and the Medical College of Wisconsin sequencing facilities. Primers
included sequences near each end of pBKS, near the ends of Tn5, and nucleotide stretches
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revealed in the rhizobial DNA. Only sequences that were verified by multiple overlapping
sequencing runs are reported here.
Construction of Plasmids pJBQ2 and pJBQ3, Which Complement Allele lpsQ166
A 1.7-kb stretch of DNA that included the lpsQ ORF was amplified by PCR, using CE3
DNA as template. The forward primer was 5'-TTCATCAGGTCTCACATGCA-3', and the reverse
primer was 5'-CTTCACTTCGGTACTGTTCG-3'. The resulting PCR product was ligated into
plasmid pCR2.1 (Invitrogen), yielding plasmid pJBQ1. It was then subcloned into plasmid vectors
pFAJ1700 (to give pJBQ2) and pFAJ1708 (to give pJBQ3). These vectors can be transferred to
and replicate in R. etli (15). pJBQ2 was constructed by inserting an EcoRI fragment from pJBQ1
into the EcoRI site of pFAJ1700. The lpsQ PCR product cloned in pJBQ3 was inserted in
pFAJ1708 following digestion of both pJBQ1 and pFAJ1708 by enzymes XbaI and SacI such
that the lpsQ ORF would be transcribed downstream of the nptII promoter of pFAJ1708.
Plasmids pJBQ2 and pJBQ3 were transferred from E. coli INVαF' cells into strain CE166 in
mating mixtures containing E. coli MT616 and Tra+ mobilizer plasmid pRK600 (16).

Results
NMR Analyses and Initial Comparison of the Parent and Mutant Strain O-polysaccharides
Evaluation of the glycosyl composition of the three different OPSs using standard
derivatization procedures (trimethylsilyl methyl glycosides and alditol acetates of neutral and
amino sugars) gave results consistent with previous analyses (5, 8), showing that the OPSs from
mutants CE166 and CE166α were greatly diminished in QuiNAc (residue B in Fig. 1) compared
with the parent strain CE3. The finding of detectable levels of QuiNAc in these preparations
differed somewhat from results previously reported for CE166 OPS in which QuiNAc was
essentially undetectable (accounting for <5% of parent strain levels) (6). NMR analysis of the
OPSs (Fig. 2) showed that the ratio of O-acetyl to N-acetyl methyl protons of the CE166 OPS
was approximately the same as that of the parent; 4.4 versus 4.0. A similar ratio was observed
for the CE166α OPS (not shown). These results, together with the greatly decreased level of
QuiNAc, suggested that both mutant OPSs contained an unidentified glycosyl residue that, like
QuiNAc, carries an N-acetyl group.
Molecular Size of the Parent and Mutant Strain O-polysaccharides
ESI-MS analysis (Fig. 3) indicated that all three of the OPSs (as released from LPS by
mild acid hydrolysis) have a similar molecular mass, each yielding several families of multiply
charged ions. In Fig. 3A, the parent strain OPS yields two doubly charged ion families (I and II,
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from high to lower mass, respectively), which differ by 202 mass units (∆ m/z = 101), reflecting
partial loss of an anhydro-Kdo residue from the reducing terminus of the O-chain. As previously
reported (5), this loss occurs in approximately one-third of the OPS molecules during the mild
hydrolytic step and is a function of hydrolysis time. Based on the observed mass differences and
the known structure of the parent OPS (5), family I ions should consist of molecules terminating
in anhydro-Kdo, and family II ions should consist of molecules terminating in QuiNAc.
In Fig. 3B, these two ion families were again observed for the CE166 OPS, together with
a third ion family (III) not observed in the parent OPS. This new, doubly charged ion family was
also observed in the CE166α OPS spectrum (not shown). A predominant mass difference
between representative ions from family II and family III is 187 mass units (∆ m/z = 93.5),
suggesting the loss of a QuiNAc residue. Thus, family II ions are consistent with the structure R
→ Fuc → Man → QuiNAc (where R represents OPS repeating units plus capping residue; see
Fig. 1), and family III ions are consistent with an R → Fuc → Man structure. For the mutant
samples, the presence of QuiNAc-containing structures was somewhat unexpected, since these
OPSs contained greatly reduced levels of QuiNAc. However, as stated above, the NMR
spectrum indicated that the level of N-acetyl groups in the mutant OPS was very similar to that in
the parent OPS, suggesting that the mutant contained an unidentified component, “X,” which
was N-acetylated. Aside from variations arising from O-acetyl and methyl group content, the
similar m/z values of the mutant OPS ions with those of the parent imply that compound X would
have a mass very similar to that of QuiNAc. If this were the case, then the mutant group I ions
would consist of a mixture of R → Fuc → Man → QuiNAc → anhydro-Kdo and R → Fuc → Man
→ X → anhydro-Kdo components, and the group II ions would arise from the structures R → Fuc
→ Man → QuiNAc and R → Fuc → Man → X, assuming that X was a direct replacement for the
QuiNAc residue.
One explanation for the existence of the group III ions in the mutant spectra is that the
unidentified component is somewhat labile to the mild acid hydrolysis conditions and is partially
removed during this procedure. A second possibility is that the mutant is able to form an R → Fuc
→ Man → Kdo sequence rather than the normal R → Fuc → Man → QuiNAc → Kdo due, for
example, to the direct addition of Man II to Kdo III (residues A and C in Fig. 1) by the inner core
LpcC mannosyl transferase. If this were the case, then, considering the specificity of LpcC, the
Man II residue would be linked to O-5 of Kdo III. However, methylation analysis (not shown)
showed that the mutant OPS contained only the expected 4-linked Kdo, making it unlikely that
LpcC adds a Man to Kdo III.
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Identification of 2-Acetamido-2,6-dideoxyhexosyl-4-ulose
The NMR and mass spectrometry data suggested that the mutant OPSs contained an
unidentified, N-acetylated component, having a mass very similar to that of QuiNAc. As stated
above, composition analyses using standard derivatization procedures failed to reveal any
significant differences among the polysaccharides aside from the aforementioned reduction in
QuiNAc in both mutant OPSs. Considering the possibility that the unidentified component might
also contain a carboxyl or other carbonyl function, in addition to the proposed N-acetyl group, the
“carboxyl-reduced” alditol acetates were prepared and analyzed. The results (Table I) confirmed
that the OPSs from CE166 and CE166α are greatly diminished in QuiNAc, as expected.
Interestingly, a series of new glycosyl residues were observed that were present only in the
mutant OPSs. These residues were identified from their mass spectra as structural
(configurational) isomers of QuiNAc. The GC-MS profiles and representative spectrum of these
components are shown in Fig. 4 and are consistent with alditol acetates of various
2-acetamido-2,6-dideoxyhexosyl residues (epimers, having different retention times) each
containing a single deuterium atom at C-4. Such residues would result from borodeuteride
reduction of a 2-acetamido-2,6-dideoxyhexosyl-4-ulose residue. As shown by methylation
analysis (see below), the deuterium was located exclusively at C-4 in all epimer derivatives. Thus,
nonstereospecific reduction at C-4 would yield both the 4-deuterio-QuiNAc, (confirmed by its
mass spectrum and co-chromatography with authentic QuiNAc) and its galacto isomer
(N-acetyl-4-deuteriofucosamine). The two remaining C-4-deuterated derivatives are derived from
reduction of the 4-ulose C-3 epimer, which most likely results from keto-enol isomerization of the
4-ulose residue prior to or during reduction.
The three OPS samples were prereduced (to stabilize the reducing end residue) and
subjected to methylation analysis. The parent strain OPS yielded only the expected 3-linked
QuiNAc derivative as reported previously (5). However, both mutant OPSs contained a series of
new derivatives, representing the epimers of the 3-linked QuiNAc residue. The mass spectra of
each derivative revealed that all epimers were deuterated at C-4, and all were 3-linked, each
yielding a partially methylated alditol acetate,
2-N-methylacetamido-1,3,5-tri-O-acetyl-4-O-methyl-1,4-di-deuterio-2,6-dideoxyhexitol (having
different configurations) as evidenced by primary fragment ions m/z 159, 289, 276, and 132 (data
not shown). Each of the latter three ions is 1 mass unit higher than the corresponding ions
derived from the nondeuterated parent strain compound and conclusively localizes deuterium
attachment to C-4. Secondary ions m/z 202 (from 276) and m/z 90 (from 132) further prove the
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location of deuterium to be C-4. Together these results show that a 3-linked
2-acetamido-2,6-dideoxyhexosyl-4-ulose residue occurs in the mutant OPS and is consistent
with the conclusion that, in the mutant structure, it has replaced the 3-linked QuiNAc residue of
the parental OPS.
Labeling and Identification of the Reducing End Residue
In order to identify the glycosyl residues at the reducing end of the various OPS, samples
were reduced with borodeuteride and then hydrolyzed and acetylated, yielding the α/β
peracetates of all internal residues and the deuterated alditol of the reducing end residue. A
comparison of the results obtained for the parent and mutant strain OPSs is shown in Fig. 5. The
parent strain (Fig. 5B) yielded the α/β peracetates of QuiNAc (originating from molecules
terminating in Kdo) and the alditol of QuiNAc, indicating that a portion of the parent OPS lacked
Kdo, thereby terminating at the reducing end with QuiNAc. These results are consistent with the
ESI-MS analyses (Fig. 3A) showing that the parent OPS preparation contains two families of ions
consistent with R → Fuc → Man → QuiNAc → Kdo and R → Fuc → Man → QuiNAc structures.
The mutant OPS (Fig. 5A) preparations yielded the α/β peracetates of QuiNAc (originating from
molecules terminating in Kdo), the alditol of QuiNAc (originating from molecules terminating in
QuiNAc), and substantial amounts of the alditol of Man (from molecules terminating in Man). In
addition, the QuiNAc alditol detected in the mutant OPS co-eluted with a small percentage of its
C-4 deuterated analogue (2-acetamido-4-deuterio-2,6dideoxyglucitol), as evident from the mass
spectra (analogous to that shown in Fig. 5). The occurrence of the C-4-deuterated alditol
supports the conclusion that the 2-acetamido-2,6dideoxyhexosyl-4-ulose residue is at the same
location in the mutant OPS as is QuiNAc in the parent OPS. In the mutants, the presence of OPS
molecules terminating in Man (Fig. 3B)or Man-ol (following reduction) (Fig. 4) is again attributed
to acid lability of the 4-hexulose residue. The low yield of 4-deuterio-HexNAc derivatives
observed in the mutant OPS using this protocol is probably due to incomplete reduction of the
4-keto group (due to only a single reduction step) and subsequent degradation, resulting in OPS
with the reducing end Man residue. Thus, the unique structures observed in the mutant OPS are
R → Fuc → Man, R → Fuc → Man → X, and R → Fuc → Man → X → Kdo.
Depolymerization of the OPSs and Analysis of Oligosaccharides
To further characterize the outer core glycosyl sequence at the reducing end of the
mutant OPSs, the OPSs were subjected to alkali-catalyzed β-elimination. It was previously
shown that treating the parent strain OPS with alkali causes β-elimination of the uronosyl
residues, leading to depolymerization of the repeating units and leaving the nonrepeating
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oligosaccharide regions of the OPS, lacking uronic acid, essentially intact (5). In the case of the
parent OPS, these nonrepeating, alkali-stable regions consist mainly of glycosyl sequences that
originate from the reducing end of the OPS (e.g. R → Fuc → Man → QuiNAc → Kdo, where R
represents variable portions of a single OPS repeating unit, and Kdo represents the inner core
Kdo III residue) (5). Further, partial β-elimination of the 3-linked QuiNAc residue may also occur
during this procedure (5); nevertheless, there is enrichment of the outer core oligosaccharide
region of the OPS due to degradation of the OPS repeating units.
This procedure was applied to both the CE166 and CE166α OPS, and the resulting
alkali-resistant oligosaccharides were fractionated by SEC and then analyzed by ESI-MS,
glycosyl composition, and linkage analyses. Two major SEC fractions were obtained for both the
CE166 and CE166α mutants, and their ESI-MS spectra are shown in Fig. 6. Each SEC fraction
consisted of a number of oligosaccharides, and their observed ions and proposed formulas are
summarized in Table II. Both mutant OPS yielded several unique oligosaccharides, in addition to
products identified previously in the parent OPS (5). One of these unique oligosaccharides
(OS-1) has a mass (m/z 794.5) supporting a R → Fuc → Man-ol structure, consistent with the
data described above. This oligosaccharide was abundant in the mutant spectra, particularly in
the lower molecular weight SEC fraction (Fig. 6B), and was detected only at low levels in the
parent strain spectrum (not shown). Other oligosaccharides, detected only in the mutant spectra,
include the species at m/z 982.5 (OS-3, R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc-ol), m/z
1181.8 (OS-7, R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc → anhydro-Kdo), and m/z
1202.8 (OS-9, R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc →Kdo-ol) (Fig. 6A). These ions
are shifted 1 mass unit higher than their parent strain counterparts, consistent with the presence
of a 4-C deuterio analogue of QuiNAc. The nondeuterated oligosaccharides, which contain
QuiNAc, are also observed in the mutant spectra (compare OS-6 at m/z 1180.8 versus OS-7 at
m/z 1181.8, and compare OS-8 at m/z 1201.8 versus OS-9 at m/z 1202.8). The presence of a
6-deoxy-4-deuterio-HexNAc residue in OS-7 and OS-9 is consistent with the results described
above that show borodeuteride reduction at C-4 of the hex-4-ulosyl residue. In Fig. 6, the
spectrum shows that the ion intensity of R → Fuc → Man → QuiNAc → anhydro-Kdo (m/z
1180.8) is greater than that of R → Fuc → Man → 6-deoxy-4-deuterio-HexNAc → anhydro-Kdo
(m/z 1181.8). This result was not consistent with the composition data, which show that the
mutant OPS contains only a low level of QuiNAc. However, as described above, a possible
explanation of this apparent discrepancy is that the 4-keto group of
2-acetamido-2,6-dideoxyhexosyl-4-ulose is only partially reduced during the single prereduction
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step prior to the β-elimination and ESI analysis, and the remaining nonreduced hex-4-ulose
residue is subsequently degraded during the alkaline treatment. Since oligosaccharides
containing the 2-acetamido-2,6-dideoxyhexosyl-4-ulose residue would show a decrement of 2
mass units compared with their normal counterparts (i.e. those containing QuiNAc), degradation
of the 2-acetamido-2,6-dideoxyhexosyl-4-ulose residue would also account for the absence of
any molecular species having a mass decrement of 2 mass units.
The Genetic Locus Mutated in Strain CE166
DNA carrying the Tn5 insertion in CE166 was cloned, and the sequence of a stretch of
2971 nucleotides was determined, as summarized in Fig. 7A. The Tn5 had inserted within an
ORF designated as lpsQ that encodes a hypothetical polypeptide of 309 amino acids. The
predicted LpsQ amino acid sequence falls within the large WcaG family of epimerases and
reductases involved in deoxyhexose synthesis (www.ncbi.nlm.nih.gov/Structure/cdd/). Matched
against ORF translation products whose functions have been studied by mutation analysis, LpsQ
shows the greatest sequence alignment with WbpV and WbpK of Pseudomonas aeruginosa
serotypes O6 and O5 (17). All three predicted proteins align throughout their sequences (Fig. 7B),
the closest alignment being between WbpV and LpsQ (47% identity, 64% similarity). As noted in
Fig. 7B, LpsQ and its homologs have the GXXGXXG motif for binding NAD(P) and a triad of
amino acids (SXnYX3K) that are conserved among ORFs in the WcaG family. These latter three
amino acids are at the active sites of WcaG (GDP-4-keto-6-deoxy-D-mannose
epimerase/reductase) (18), GalE (UDP-galactose 4-epimerase) (19), and most of the studied
examples within the larger family of short-chain dehydrogenases/reductases (20).
lpsQ is flanked by two ORFs homologous to highly conserved eubacterial genes, murB
and ddlB, whose transcription is oriented oppositely to that of lpsQ (Fig. 7A). murB and ddlB are
involved in peptidoglycan synthesis and are generally contiguous in the genomes of other
α-proteobacteria (21–24); murB encodes UDP-N-acetylmuramate dehydrogenase, and ddlB
encodes D-alanylalanine synthase. The 63 amino acids encoded by the deduced ddlB fragment
were 76% identical and 87% similar to the N-terminal 63 amino acids encoded by the presumed
ddlB of Sinorhizobium meliloti (25). The 279 amino acids encoded by the deduced murB
fragment were 76% identical and 87% similar to the corresponding C-terminal amino acids
encoded by the presumed murB of S. meliloti (25).
A PCR product from wild-type R. etli strain CE3 containing lpsQ that extends from
nucleotide 260 to 1969 in Fig. 7A, was cloned into broad host vectors pFAJ1700 and FAJ1708.
When either construct was transferred into strain CE166, normal LPS I abundance, normal
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QuiNAc content, and normal symbiotic proficiency were restored (data not shown).

Discussion
The OPSs released by mild acid hydrolysis of the LPSs from the R. etli CE3 mutants,
CE166 and CE166α, were shown to have the following structures: R → Fuc → Man → QuiNAc
→ Kdo (1), R → Fuc → Man → QuiNAc (2), R → Fuc → Man → X → Kdo (3), R → Fuc → Man
→ X(4), and R → Fuc → Man (5), where R represents the repeating unit oligosaccharide and
capping residue as shown in Fig. 1 and where X has been identified as
2-acetamido-2,6-dideoxyhexosyl-4-ulose. The low levels of QuiNAc in these mutant LPSs imply
that structures 1 and 2 are present in minor amounts. Structures 2 and 4 are due to the
elimination of Kdo from a portion of the molecules during the mild acid hydrolytic release of OPS
from the LPS; partial loss of this Kdo has also been reported as occurring during isolation of the
parent strain OPS (5). Structure 5 is probably due to the elimination of the
2-acetamido-2,6-dideoxyhexosyl-4-ulose residue, also during the mild acid hydrolysis
procedure. From these results it can be concluded that the R. etli CE3 mutants, CE166 and
CE166α, produce LPSs in which the outer core oligosaccharide has two structures, 6 and 7,
shown in Fig. 8. Structure 6 is normally found in the OPS from the parent strain, whereas
structure 7 is found in the mutant OPSs and is not present in the parent. In structure 7, the
QuiNAc is replaced by 2-acetamido-2,6-dideoxyhexosyl-4-ulose. Although rare in
polysaccharides, 2-acetamido-2,6-dideoxy-D-xylo-hexos-4-ulose was first identified as a
component of the pentasaccharide repeating unit in the capsular polysaccharide synthesized by
Streptococcus pneumoniae type 5 (26). In LPS, two occurrences of this glycose have been
reported, as a component of the tetrasaccharide repeating unit in the OPS from Vibrio ordalii
serotype O:2 (27) and recently in the OPS repeating unit from Flavobacterium columnare ATCC
43622 (28). In all reported occurrences, the glycose is 3-linked and is part of a repeating unit
that comprises a polysaccharide. In the case of the R. etli CE166 mutant, the glycose occurs as
a single residue in the outer core portion and is not part of the OPS repeating unit. To our
knowledge, this is the first example of a core region glycose residue being replaced by its
biosynthetic precursor.
The relative amounts of these two structures present in these LPS preparations from
CE166 and CE166α can be estimated from the composition data shown in Table II. This
calculation is based on the assumption that the OPS from the parent exists exclusively as
structure 6 and, therefore, that the level of QuiNAc in the parent OPS represents the total molar
12 Forsberg, Noel, Box, & Carlson

fraction amount of QuiNAc present in an OPS preparation in which all molecules contain QuiNAc.
Thus, in CE166 the percentage of structure 6 can be calculated from the mutant to parent molar
QuiNAc ratio (see Table I), 0.13/0.62 or 21%, which implies that structure 7 comprises the
remainder of the CE166 LPS, or 79%. Similarly, in the CE166α OPS, the percentages of
structures 6 and 7 are 10% (0.06/0.62), and 90%, respectively.
The presence of small amounts of structure 6 in the mutant OPSs is a slightly different
result from what would have been predicted from our previous report (8) in which the LPSs from
CE166 and CE166α did not contain detectable levels of QuiNAc. One possible explanation for
this difference in the two preparations is reversion. Initial studies with this mutant indicated that at
low frequency it underwent an unusual type of reversion in which the Tn5 ended up in another
replicon of the bacterium (29). Later studies could not reproduce this result. A second related
possibility is extragenic suppression. Suppressor mutations may allow detectable QuiNAc
synthesis by occurring in a second, cryptic copy of lpsQ or a gene encoding a 4-reductase
normally involved in synthesis of another deoxysugar. Both of these possibilities would be
consistent with not observing QuiNAc in some cases (8) and observing a small amount in other
cases (3). It should also be noted that the CE166α LPS, while containing almost parental levels
of OPS, has much less QuiNAc than does the mutant CE166 LPS. Thus, whereas the current
results are not identical to those previously reported with regard to the level of QuiNAc, it is clear
that the lps-166 mutation results in an LPS that is very deficient in the level of QuiNAc and,
therefore, in the amount of the normal parental structure 6.
In the major mutant structure 7, the QuiNAc residue normally present in the parental LPS
(i.e. structure 6) has been replaced by its presumed 4-keto precursor,
2-acetamido-2,6-dideoxyhexosyl-4-ulose. Since QuiNAc is an essential sugar involved in joining
the OPS to the core region of the LPS, the presence of the 4-keto precursor in place of QuiNAc
suggests that the UDP-QuiNAc transferase is able to use
UDP-2-acetamido-2,6-dideoxyhexosyl-4-ulose as a substrate. The lower level of OPS in CE166
compared with that in the parent CE3 would imply that this transferase uses
UDP-N-acetyl-2-amino-6-deoxyhexosyl-4-ulose less efficiently than UDP-QuiNAc; i.e. it is likely
not to recognize the 4-ulose as well as QuiNAc. The fact that CE166α, which contains multiple
copies of the lps α-region, produces LPS with close to the normal level of OPS but containing
N-acetyl-6-deoxyhexosyl-4-ulose in place of QuiNAc suggests that this transferase may be
located on the lps α-region, and its overexpression allows more OPS to be made and
subsequently added to the LPS core region.
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The suggested biosynthetic pathway of D-QuiNAc is shown in Fig. 9. In this pathway,
UDP-GlcNAc is converted into UDP-QuiNAc by two enzymatic activities: a 4,6-dehydratase,
which forms UDP-N-acetyl-6-deoxyhexosyl-4-ulose from UDP-Glc-NAc, and a reductase, which
stereospecifically reduces UDP-N-acetyl-6-deoxyhexosyl-4-ulose to UDP-QuiNAc. This work
provides evidence for the assignment of LpsQ to the second step of QuiNAc synthesis (Fig. 9),
since the lpsQ mutation allows the synthesis of the keto intermediate and highly abrogates the
production of QuiNAc itself.
In vitro studies with two proteins have indicated that a single enzyme may catalyze both
of the above steps in the synthesis of D-QuiNAc from D-GlcNAc (30–32). These two proteins are
encoded by genes wbpM of P. aeruginosa (30) and flaA1 of Helicobacter pylori (31). However,
the predicted LpsQ ORF exhibits very little sequence similarity to these proteins. In paired
comparisons by the Blast2 program (www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html), the FlaA1
sequence yields an alignment with LpsQ of low significance (“expect value” e-3), and this
program finds no significant overall homology between LpsQ and WbpM. By contrast, FlaA1 and
WbpM sequences align in a clearly significant manner (giving an expect value of 2e-25). They
would appear to be in a different subfamily of the NDP-sugar dehydratase/epimerase/reductases
within the larger family of short-chain dehydrogenase/reductases (20). There is also a recently
proposed pathway for synthesis of L-QuiNAc, involving five steps catalyzed in vitro by three
enzymes (33). In Blast2 and ClustalW analysis, LpsQ shows little or no significant sequence
similarity to any of the proteins thus far assigned to this pathway.
Despite the existence of the apparently bifunctional enzymes WbpM and FlaA1, it still
seems plausible that QuiNAc may be synthesized through the action of two separate enzymes, a
dehydratase and a reductase (Fig. 9). However, if such is the case in R. etli, it is surprising that
the gene for the first step (the hydratase) appears not to be contiguous with lpsQ. It was already
surprising that lpsQ was not closely linked with other genes of R. etli CE3 that are required for its
LPS core and O-antigen (3, 8, 34). However, it should be pointed out that many of the genes for
LPS core synthesis in R. etli have not been identified. It also should be pointed out that R. etli
appears to be especially prone to gene duplications and transpositions of small and long
segments of DNA (29). There may be another (less active) copy of lpsQ, which is contiguous
with an unduplicated gene that specifies the first step in Fig. 9. lpsQ appears to reside within a
suite of cell wall synthesis genes. Generally, murB and ddlB are contiguous in other
α-proteobacteria; however, there is precedent for an insertion between them. In S. meliloti, two
hypothetical genes have been inserted between ddlB and murB (25). These two hypothetical
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genes, coding for an aquaporin and a possible transport protein, as with lpsQ, are also not
related to cell wall synthesis proteins. It is possible that this site may be a target for a type of
transposition event that inserts various genes.
A number of subtle structural changes have been reported to occur to the OPS portion of
R. etli CE3 LPS during symbiosis. These changes have been detected using monoclonal
antibodies that are specific to the OPS portion of the LPS and involve methylation of the Fuc
residues (8, 13, 35). During nodulation, the reactivity of the OPS for two of four mAbs greatly
decreases (36). The binding of these mAbs involves, in part, the terminal capping TOMFuc
residue (35) and a 2MeFuc residue2 either in the repeat unit or in the outer core region (see the
structure shown in Fig. 1). The CE166 and CE166α mutants do not differ from the parent with
regard to their ability to bind these mAbs, and therefore, there apparently is no difference from
the parent OPS in these fucosyl residues. Indeed, strain CE166α (8) produces parental levels of
OPS, which, while deficient in QuiNAc, has a structure that is otherwise the same as the parent
CE3 OPS as reflected by composition, mass spectrometric, NMR, and monoclonal antibody
binding data (this report) (8). This very minor chemical change (i.e. replacement of QuiNAc with
its 4-keto precursor) results in an altered nodulation phenotype (i.e. nodulation is delayed, and
the distribution of nodules is altered) (8), suggesting that it produces a structural change that is
significant enough to affect its role in symbiosis. In addition, this result suggests that structural
features of this outer core region of CE3 LPS, in addition to changes in the methylation pattern of
TOMFuc and Fuc residues, are involved in establishing symbiosis with the host legume.
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Appendix
Table 1
Glycosyl composition of R. etli parent and mutant strain O-polysaccharides as determined by
GC-MS analysis of the derived, carboxyl-reduced, alditol acetates

Glycosyl reside
2,3,4-MeFuc
2,3-MeFuc
2-MeFuc
3-Me-6-deoxyTalb
Fuc
Man
GlcAc
Kdod
QuiNAc
6-dexoxy-4-D-HexNAce
a

CE3
0.98
0.0
0.63
4.30
3.87
1.00
3.84
0.71
0.62

Molar ratioa
CE166
CE166-α
0.59
0.90
0.64
0.12
0.88
0.52
4.10
3.81
3.56
2.80
1.00
1.00
3.98
3.08
0.93
1.04
0.13
0.06
0.38
0.50

Ratios normalized to Man, determined from the GC-MS total ion current peak areas of the alditol acetates
with response factor correction from authentic standards. Partially methylated standards of
6-deoxytalose were obtained from a Streptococcal type-specific polysaccharide, and the R. etli parent
strain OPS served as a source of authentic QuiNAc as previously described (5).
b
3-Me-6-deoxyTal, 3-O-methyl 6-deoxytalose.
c
Determined as the carboxyl-reduced alditol acetate, containing two deuteriums at C-6.
d
Determined as the carboxyl-reduced alditol acetate, containing two deuteriums at C-1.
e
D-HexNAc, 2-acetamido-2,6-dideoxyhexose, determined as the keto-reduced alditol acetate, derived
from the corresponding hex-4-ulose and containing one deuterium atom at C-4
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Table 2
Ions derived from electrospray analysis and proposed formulas of the reducing end oligosaccharides produced from
β-elimination of the R. etli mutant strain CE166 OPS
Observed
iona
794.5
981.5
982.5
1020.5
1041.5
1180.8
1181.8
1201.8
1202.8

Experimental
mass
793.5 OS-1
793.8 + H+1
980.5 OS-2
980.9 + H+1
981.5 OS-3
981.9 + H+1
1019.5 OS-4
1019.9 + H+1
1040.5 OS-5
1040.9 + H+1
1179.8 OS-6
1180.1 + H+1
1180.8 OS-7
1181.1 + H+1
1200.8 OS-8
1201.1 + H+1
1201.8 OS-9
1202.1 + H+1

a

Calculated mass and proposed formulab
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man-ol1] + H+
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man1QuiNAc-ol1] + H+
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man14-D-HexNAc-ol1] + H+
M + H+1
[∆4,5GlcA1Fuc2Man1QuiNAc12,7anhydKdo1] + H+
M + H+1
[∆4,5GlcA1Fuc2Man1QuiNAc1Kdo-ol1] + H+
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man1QuiNAc12,7anhydKdo1] + H+
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man14-D-HexNAc12,7anhydKdo1] + H+
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man1QuiNAc1Kdo-ol1] + H+
M + H+1
[∆4,5GlcA13Me6dTal1Fuc2Man14-D-HexNAc1Kdo-ol1] + H+

Predicted
ionc
794.8
982.0
983.0
1020.9
1042.0
1181.1
1182.1
1202.1
1203.1

A mass step of 0.2 atomic mass units was used during analysis.
Calculated from the average incremental mass of the component glycosyl residues as described under “Experimental Procedures.” The proposed
formulas of OS-6 and OS-8 are identical to those detected in the parent OPS (5). Glycosyl composition and linkage analysis of the mutant SEC
fractions resulting from β-elimination confirmed the presence of 3-linked Man-ol, 3-QuiNAc-ol, and 3-(4-D-HexNAc) in the appropriate SEC
fractions (data not shown). Oligosaccharides OS-4 and OS-5 appear to arise from OS-6 and OS-8, respectively, due to loss of a terminal
4,5
3Me6dTal residue; the 3Me6dTal is linked 1 → 3 to fucosyl residues in OS-6 and OS-8 (5). ∆ GlcA, 4-deoxyhex-4-enopyranosiduronate;
3Me6dTal, 3-O-methyl-6-deoxytalose; 2,7anhydKdo, 2,7-anhydro-Kdof; Kdo-ol, Kdo reduced at C-2 with borodeuteride; Man-ol, Man reduced at
C-1 with borodeuteride; QuiNAc-ol, QuiNAc reduced at C-1 with borodeuteride, etc.
c
The predicted singly charged ion as determined from the proposed formula.
b
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Figure 1
The complete glycosyl sequence of the carbohydrate portion of R. etli CE3 LPS

The OPS portion contains a nonrepeated trisaccharide at its reducing end defined as the outer core
(residues B–D) that links the repeating units to the inner core region. Mild hydrolytic treatment of the LPS
cleaves at ketosidic linkages, and the released OPS terminates in Kdo (residue A). The extent of
O-methylation of the fucosyl residues is indicated (5).

Figure 2
The proton NMR spectra of the OPS from R. etli CE3 LPS (A) and the OPS from R. etli
CE166 LPS (B)
The resonances for the anomeric, methoxyl, C-6
methyl, and N- and O-acetyl methyl protons are as
indicated.
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Figure 3
Positive ion ESI-MS spectra of the intact (native) OPS released by mild hydrolysis from
the parent strain CE3 (A), and the CE166 mutant (B).
Protonated doubly and triply
charged ions are observed in both
spectra. Among doubly charged
2+
ions (M + 2H) , ions within each
family differ by ±7 m/z (14 mass
units), reflecting heterogeneity in the
degree of endogenous
O-methylation. The triply charged
ions differ by 4.7 m/z (rounded to
∆=5 m/z as shown). In A, the
observed ion m/z 1749
(experimental mass 3496)
corresponds to a molecular
component (lactone form) having
the following formula:
TOMeFuc1GlcA4(OAc)4-GlcAMe13M
e6dTal5Fuc52MeFuc1Man1-QuiNAc1
anhydro-Kdo1 (calculated mass
3494.3, predicted ion 1748.2). The
electrospray technique tends to
induce lactonization of carboxylated
polysaccharides, resulting in a loss
of a single H2O from such species,
presumably at the Kdo (or a GlcA)
residue. Variation in O-acetyl
content (± m/z 21; 42 mass units)
also contributes to the multiplicity of
ions within each family. B, the
somewhat higher m/z values for the
mutant, compared with the parent
OPSs are consistent with an
increase in O-acetyl and/or methyl
groups (e.g. m/z 1784 compared
with 1749 can be accounted for by
one additional O-acetyl (+m/z 21)
and two additional methyl groups
(+m/z 14). Such differences could
arise from variations in the mild acid
hydrolysis conditions, storage time
of the OPS in solution, or normal
batch to batch variations in LPS. In
B, the CE166 mutant OPS contains
a third ion family, representing one
aspect of the mutation (see
“Results”). The spectrum of the CE166α OPS (not shown) is similar to that of CE166. Q, QuiNAc; X,
analogue of QuiNAc; M, mannose; K, anhydro-Kdo; R, the repeating unit portion of the OPS. The anhydro
forms of Kdo are generated during the mild hydrolytic release of OPS (5).
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Figure 4
GC-MS analysis of the amino
sugar components in parent and
mutant strain OPSs
A, comparison of the total ion
chromatograms of the carboxyl-reduced
alditol acetates derived from the parent
(top) and CE166 mutant (bottom) OPSs;
the arrows mark the location of
deuterated analogues of QuiNAc. Minor
components eluting between 52 and 57
min are by-products of the Kdo
derivatization. B, electron impact mass
spectrum and fragmentation scheme of
one of the deuterated amino sugar
analogues detected in the CE166 and
CE166α mutant OPSs. It is noteworthy
that traces of the C-4 deuterated alditols
were also detected during the
preparation of the normal alditol
acetates; however, their yields were
increased during preparation of the
carboxyl-reduced derivatives, a
procedure that involves two additional
treatments with borodeuteride (see
“Experimental Procedures”).
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Figure 5
Labeling and comparison of the reducing end residues of the OPSs by GC-MS analysis

The native OPSs were reduced with borodeuteride and then hydrolyzed and acetylated, yielding the
peracetates of all internal residues and the deuterated alditols of the reducing end residues. A, the CE166
mutant OPS yields a small amount of QuiNAc-ol, co-eluting with 4-deuterio-QuiNAc-ol (identified from the
mass spectrum of its alditol acetate), and Man-ol. The α/β peracetates of QuiNAc, and 4-deuterio-QuiNAc
(which co-elute) were also observed; B, the parent strain OPS yielded primarily the QuiNAc α/β
peracetates and lesser amounts of QuiNAc-ol, confirming the structural assignments for the ion families
obtained by ESI-MS (see Fig. 3). The Kdo alditol derivative, visible in Fig. 4, is not produced under these
conditions (see “Experimental Procedures”). All three OPS samples contained a percentage of molecules
terminating in Kdo, revealed by the “carboxyl-reduced alditols” (Fig. 4) and by the ESI-MS analysis (Fig. 3).
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Figure 6
Positive ion ESI-MS spectra of oligosaccharides derived from base-catalyzed β
-elimination of the CE166 mutant OPS.
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The OPS was prereduced with borodeuteride to stabilize the reducing end to alkali, subjected to
β-elimination, and fractionated by SEC. The two major SEC fractions were analyzed: the higher molecular
weight fraction that is enriched in oligosaccharides originating from the reducing end of the OPS and
terminating in anhydro-Kdo or Kdo-ol (A) and the lower molecular weight fraction that is enriched in
reducing end oligosaccharides terminating in Man-ol, QuiNAc-ol, or
2-N-acetamido-4-deuterio-2,6-dideoxyhexitol (B). These oligosaccharides represent different forms of the
reducing end of the OPS; all reducing end residues have been reduced with borodeuteride except for
those terminating in 2,7-anhydro-Kdo residues, which arise during the mild hydrolytic release of the OPS
(5) and resist reduction. All of these oligosaccharides terminate at the nonreducing end with a
4-deoxyhex-4-enopyranosyluronic acid residue, resulting from elimination of the 4-O-substituent from the
1+
glucuronosyl residues (5). All molecular ions are of the formula (M + H) , and their structures are
summarized in Table II. Oligosaccharides originating from the nonreducing end of the OPS co-eluted
during SEC and are also visible in the spectra; their masses and structures are identical to those described
previously for the parent OPS (5) and include species at m/z 703, m/z 689, m/z 543, and m/z 529. The ion
(*) is a contaminant in the solvent.
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Figure 7
A, the DNA locus mutated in strain CE166

The numbers refer to nucleotides, with position 1 on the leftmost end being the first of the 2971 nucleotides
whose sequence was determined at this locus. A stretch of 34 nucleotide pairs upstream of ddlB
(nucleotides 431–465) are almost exactly conserved between S. meliloti, Agrobacterium tumefaciens, and
this R. etli sequence. This stretch is probably the promoter for ddlB; it has a very strong match with
consensus σ70-type promoters. A weaker match with σ70-type promoters, oriented toward lpsQ, is
indicated by P?. Above the predicted ORFs is shown the expanse of DNA that was amplified from
wild-type strain CE3 by PCR, which restores CE166 to LpsQ+ phenotypes when cloned in vectors
pFAJ1700 and pFAJ1708. B, alignment of the predicted LpsQ amino acid sequence with the sequences of
two homologs from P. aeruginosa by use of the ClustalW program (37) (available on the World Wide Web
at www.ebi.ac.uk/clustalw/index.html). Boldface letters within shaded areas indicate the GXXGXXG motif
for NAD(P) binding and the SXnYX3K residues commonly found at the active sites of enzymes in the SDR
superfamily (e.g. residues 114, 139, and 143 of LpsQ). The boxed string of identical residues near the C
terminus may participate in substrate specificity. It differs greatly from a stretch of residues that are
conserved among fucose synthetases at the same place in alignments of the polypeptide sequences (38).
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Figure 8
The outer core structures observed in the LPSs from R. etli CE3, and mutants CE166 and
CE166α

R represents the capping and repeating unit portion of the OPS (refer to Fig. 1 for the complete structure of
the OPS).
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Figure 9
The suggested biosynthetic scheme for the synthesis of UDP-QuiNAc
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